Cargando…
Assessment of CHADS(2) and CHA(2)DS(2)-VASc scores in obstructive sleep apnea patients with atrial fibrillation
PURPOSE: Assessment of stroke risk and implementation of appropriate antithrombotic therapy is an important issue in atrial fibrillation patients. Current risk scores do not take into consideration the comorbidities associated with elevated thromboembolic like obstructive sleep apnea (OSA). The aim...
Autores principales: | Szymanski, Filip M., Filipiak, Krzysztof J., Platek, Anna E., Hrynkiewicz-Szymanska, Anna, Karpinski, Grzegorz, Opolski, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428805/ https://www.ncbi.nlm.nih.gov/pubmed/25084983 http://dx.doi.org/10.1007/s11325-014-1042-5 |
Ejemplares similares
-
Association of the CHADS(2) and CHA(2)DS(2)-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients
por: Hrynkiewicz-Szymanska, Anna, et al.
Publicado: (2014) -
OSACS score-a new simple tool for identifying high risk for Obstructive Sleep Apnea Syndrome based on clinical parameters
por: Szymanski, Filip M., et al.
Publicado: (2015) -
Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations — a long-term prospective, cross-sectional cohort study
por: Szymanski, Filip M., et al.
Publicado: (2015) -
R(2(GFR))CHADS(2) and R(2(GFR))CHA(2)DS(2)VASc schemes improved the performance of CHADS(2) and CHA(2)DS(2)VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2017) -
Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score
por: Hung, Chen-Ying, et al.
Publicado: (2014)